Previous 10 | Next 10 |
Yield10 Bioscience, Inc. (YTEN) Q4 2019 Earnings Conference Call March 19, 2020, 04:30 PM ET Company Participants Lynne Brum - VP of Planning and Corporate Communications Oliver Peoples - President and CEO Kristi Snell - VP of Research and CSO Chuck Haaser - Chief Accounting Of...
Yield10 Bioscience (NASDAQ: YTEN ): Q4 EPS of -$12.02 may not be comparable to consensus of -$4.00. More news on: Yield10 Bioscience, Inc., Earnings news and commentary, Energy stocks news, , Read more ...
WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended December 31, 2019. "In 2019 we consistently met our milestones as we brought forward new cr...
-- 2019 Field Test Results Highlight CRISPR Technology Approach to Increase in Oil Content in Oilseed Crops -- Outlines Field Tests Planned for 2020 WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, toda...
WOBURN, Mass., March 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company, announced today that the Company will report its fourth quarter and full year 2019 financial results and provide a corporate update on Thursday, March 19, 2020. M...
Ovintiv (NYSE: OVV ) +67% after yesterday's 72% plunge . More news on: Ovintiv Inc., Cypress Semiconductor Corporation, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...
WOBURN, Mass., March 10, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that it achieved key milestones in an early development program in corn to evaluate novel seed yield traits. Corn is the highest value commercia...
WOBURN, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN today announced that Sherri M. Brown, Ph.D. was appointed to the Company’s Board of Directors effective February 11, 2020. In connection with her appointment, Dr. Brown will serve as chair of...
Myomo (NYSEMKT: MYO ) -19% . More news on: Myomo, Inc., Arbutus Biopharma Corporation, Biohaven Pharmaceutical Holding Company Ltd., Stocks on the move, , Read more ...
Assertio Therapeutics (NASDAQ: ASRT ) +63% on buying Nucynta U.S. rights from Assertio in $375M deal. More news on: Assertio Therapeutics, Inc., Yield10 Bioscience, Inc., Telenav, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...